• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Show Search
Home
EN / FR
  • LinkedIn
  • Twitter
Celyad Oncology

Celyad Oncology

  • About Us
    • Overview
    • Management Team
    • Board Of Directors
    • Scientific Advisory Board
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • TIM
      • shRNA
    • Manufacturing
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us
    • Careers
Home / Newsroom / Media Center

Media Center

Celyad Oncology Corporate Fact Sheet

Corporate Overview Fact Sheet

Allogeneic Vs. Autologous Fact Sheet

Allogeneic vs. Autologous Fact Sheet

alloSHRINK Trial Fact Sheet

alloSHRINK Trial Fact Sheet

IMMUNICY Trial Fact Sheet

IMMUNICY Trial Fact Sheet

What is NKG2D?

NKG2D Fact Sheet

shRNA Fact Sheet

shRNA Fact Sheet

What is TIM Technology?

TIM Fact Sheet

CAR T vs NK Cells

CAR T vs NK Cells

Celyad Oncology Logo

Celyad Oncology Headquarters

Lab Image

Lab Image

Celyad Oncology Manufacturing Building

Filippo Petti

Philippe Dechamps

David Gilham

Frédéric Lehmann

Philippe Nobels

Stephen Rubino

Peggy Sotiropoulou

Load More

Footer

  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.
Cookie Policy | Privacy Policy | Terms of Use